CRP Testing Market: Advancing Inflammation Diagnostics and Early Disease Detection

The CRP testing market is witnessing steady growth due to the rising global burden of inflammatory diseases, infectious conditions, and chronic disorders that require accurate and early diagnostic tools. C-reactive protein (CRP) testing is a widely used blood test that measures the level of CRP, a biomarker produced by the liver in response to inflammation. It plays a critical role in diagnosing infections, monitoring chronic diseases, and assessing cardiovascular risk.

The global C-reactive protein (CRP) testing market was valued at USD 2.9 billion in 2024. It is projected to grow at a CAGR of 8.80% from 2025 to 2034, reaching USD 3.16 billion in 2025 and expanding to USD 6.7 billion by 2034.

Market Overview

CRP testing is an essential diagnostic tool used across hospitals, clinics, and laboratories to detect inflammation levels in the body. Elevated CRP levels are associated with conditions such as bacterial infections, autoimmune diseases, cardiovascular disorders, and post-surgical complications.

The CRP testing market is expanding due to the increasing prevalence of chronic diseases such as diabetes, arthritis, and cardiovascular conditions. Additionally, the rising demand for rapid diagnostic testing and the growing use of CRP as a prognostic marker in clinical decision-making are supporting market growth.

Technological advancements in immunoturbidimetric assays, high-sensitivity CRP (hs-CRP) tests, and automated analyzers are further improving test accuracy and efficiency.

Key Market Drivers

Several important factors are driving the growth of the CRP testing market:

• Rising prevalence of infectious and inflammatory diseases
• Increasing burden of cardiovascular disorders worldwide
• Growing demand for early disease diagnosis and preventive healthcare
• Technological advancements in immunoassay and diagnostic platforms
• Expansion of point-of-care testing (POCT) solutions
• Rising awareness of personalized medicine and biomarker-based diagnostics

The increasing use of CRP testing in routine health checkups is also contributing to market expansion globally.

Segment Analysis

The CRP testing market can be segmented based on test type, technology, application, and end user.

By Test Type

The market is divided into:

• Standard CRP tests
• High-sensitivity CRP (hs-CRP) tests

High-sensitivity CRP tests dominate the market due to their ability to detect low levels of inflammation, particularly in cardiovascular risk assessment. These tests are widely used in preventive healthcare and chronic disease management.

By Technology

Key technologies include:

• Immunoturbidimetric assays
• Enzyme-linked immunosorbent assays (ELISA)
• Chemiluminescence immunoassays
• Point-of-care testing devices

Immunoturbidimetric assays hold a significant market share due to their rapid processing time and compatibility with automated laboratory systems. Meanwhile, point-of-care testing is experiencing rapid growth due to its convenience and ability to provide immediate results.

By Application

Major application areas include:

• Infectious disease diagnosis
• Cardiovascular risk assessment
• Autoimmune disease monitoring
• Inflammatory condition detection

Cardiovascular disease assessment represents a key application segment, as elevated CRP levels are strongly associated with heart disease risk. Infectious disease diagnosis also remains a major contributor to market demand.

By End User

The market is segmented into:

• Hospitals and clinics
• Diagnostic laboratories
• Research institutes
• Home care settings

Hospitals and diagnostic laboratories account for the largest share due to high patient inflow and routine use of CRP testing in clinical diagnostics. However, home care and point-of-care settings are growing rapidly due to increasing demand for decentralized healthcare solutions.

Discover the Complete Report Here:

https://www.polarismarketresearch.com/industry-analysis/c-reactive-protein-testing-market

Some of the companies working in the global CRP market include:

• Abaxis, Inc.
• Abbott, Danaher
• Aidian
• BODITECH MED, INC.
• F. Getein Biotech, Inc.
• Hoffmann-La Roche Ltd.
• HORIBA, Ltd., Inc.
• Laboratory Corporation of America Holdings
• Merck KGaA
• Ortho Clinical Diagnostics
• Quest Diagnostics
• Randox Laboratories Ltd.
• Roche Ltd.
• Siemens Healthineers AG
• Thermo Fisher Scientific
• Zoetis

Regional Analysis

North America

North America leads the CRP testing market due to advanced healthcare infrastructure, high awareness of preventive healthcare, and strong adoption of diagnostic technologies. The United States is the largest contributor, driven by rising cardiovascular disease prevalence and widespread use of biomarker-based diagnostics.

Europe

Europe holds a significant share of the market due to strong healthcare systems and increasing focus on early disease detection. Countries such as Germany, the UK, and France are actively adopting advanced CRP testing technologies in both public and private healthcare sectors.

Asia Pacific

Asia Pacific is expected to witness the fastest growth during the forecast period. Increasing healthcare expenditure, rising population, and growing awareness of early diagnosis are major growth drivers. Countries like China, India, and Japan are expanding their diagnostic infrastructure rapidly.

Latin America and Middle East & Africa

These regions are gradually adopting CRP testing due to improving healthcare access and rising disease burden. Although infrastructure limitations exist, increasing investments in healthcare modernization are expected to support future growth.

Conclusion

The CRP testing market is evolving rapidly as healthcare systems increasingly rely on biomarkers for early disease detection and management. Supported by the expanding C-Reactive Protein Testing Market, CRP testing is becoming a vital component of modern diagnostic workflows. With growing demand for rapid, accurate, and accessible testing solutions, the market is expected to witness sustained growth in the coming years.

More Trending Latest Reports By Polaris Market Research:

Myasthenia Gravis Disease Market

Rhytidectomy Market

Spatial Genomics & Transcriptomics Market

U.S. Incontinence and Ostomy Care Products Market

Medical Footwear Market

Antibiotic Resistance Market

High-Resolution Melting Analysis Market

US Cardiovascular Devices Market